Oncolytics Biotech Inc (ONC)-Financial and Strategic SWOT Analysis Review

Oncolytics Biotech Inc (ONC)-Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH63162FSA
  • |
  • Pages: 45
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Oncolytics Biotech Inc (ONC)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Oncolytics Biotech Inc (Oncolytics) is a development stage biopharmaceutical company which focuses on the discovery and development of oncolytic viruses for use as cancer therapeutics. The company's lead product, Reolysin, a formulation of the human reovirus, is at Phase II clinical trials for the treatment of lung, ovarian, colorectal, pancreatic, prostate, breast, head and neck cancers. Reolysin is also undergoing various other clinical trials to determine its use in other types of cancer, such as for squamous cell carcinoma, metastatic colorectal cancer, metastatic melanoma trial, and non-small cell lung cancer. The company and its partners are conducting clinical trials in several countries across the world, including Canada, and the US. Oncolytics is headquartered in Calgary, Alberta, Canada.

Oncolytics Biotech Inc Key Recent Developments

Mar 10,2017: Oncolytics Biotech Announces 2016 Year-End Results

Jan 19,2017: Oncolytics Biotech Appoints Dr. Matt Coffey to the Role of President and CEO

Dec 06,2016: Oncolytics Biotech announces resignation of board member

Nov 10,2016: Oncolytics Biotech Announces Appointment of New Chief Medical Officer

Nov 03,2016: Oncolytics Biotech Announces 2016 Third Quarter Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Oncolytics Biotech Inc-Key Facts 6

Oncolytics Biotech Inc-Key Employees 7

Oncolytics Biotech Inc-Key Employee Biographies 8

Oncolytics Biotech Inc-Major Products and Services 9

Oncolytics Biotech Inc-Pharmaceutical Pipeline Products Data 10

Oncolytics Biotech Inc, Pipeline Products by Therapy Area 10

Oncolytics Biotech Inc, Pipeline Products by Development Phase 11

Oncolytics Biotech Inc-History 12

Oncolytics Biotech Inc-Locations And Subsidiaries 14

Head Office 14

Other Locations & Subsidiaries 14

Section 2-Company Analysis 15

Oncolytics Biotech Inc-Business Description 15

Oncolytics Biotech Inc-Corporate Strategy 16

Oncolytics Biotech Inc-SWOT Analysis 17

SWOT Analysis-Overview 17

Oncolytics Biotech Inc-Strengths 17

Oncolytics Biotech Inc-Weaknesses 18

Oncolytics Biotech Inc-Opportunities 19

Oncolytics Biotech Inc-Threats 20

Oncolytics Biotech Inc-Key Competitors 21

Section 3-Company Financial Ratios 22

Financial Ratios-Capital Market Ratios 22

Financial Ratios-Annual Ratios 23

Performance Chart 25

Financial Performance 25

Financial Ratios-Interim Ratios 26

Financial Ratios-Ratio Charts 27

Section 4-Company's Lifesciences Financial Deals and Alliances 28

Oncolytics Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 28

Oncolytics Biotech Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 29

Oncolytics Biotech Inc, Recent Deals Summary 30

Section 5-Company's Recent Developments 31

Mar 10, 2017: Oncolytics Biotech Announces 2016 Year-End Results 31

Jan 19, 2017: Oncolytics Biotech Appoints Dr. Matt Coffey to the Role of President and CEO 32

Dec 06, 2016: Oncolytics Biotech announces resignation of board member 33

Nov 10, 2016: Oncolytics Biotech Announces Appointment of New Chief Medical Officer 34

Nov 03, 2016: Oncolytics Biotech Announces 2016 Third Quarter Results 35

Nov 02, 2016: Oncolytics Biotech Announces Management Team Changes 36

Aug 04, 2016: Oncolytics Biotech Announces 2016 Second Quarter Results 37

May 06, 2016: Oncolytics Biotech Announces 2016 First Quarter Results 38

Mar 24, 2016: Oncolytics Biotech Announces Filing of Management Information Circular and Details of 2016 Annual General Meeting 39

Mar 11, 2016: Oncolytics Biotech Announces 2015 Year End Results 40

Section 6-Appendix 41

Methodology 41

Ratio Definitions 41

About GlobalData 45

Contact Us 45

Disclaimer 45

List of Figures

Oncolytics Biotech Inc, Pipeline Products by Therapy Area 10

Oncolytics Biotech Inc, Pipeline Products by Development Phase 11

Oncolytics Biotech Inc, Performance Chart (2012-2016) 25

Oncolytics Biotech Inc, Ratio Charts 27

Oncolytics Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 28

Oncolytics Biotech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 29

List of Tables

Oncolytics Biotech Inc, Key Facts 6

Oncolytics Biotech Inc, Key Employees 7

Oncolytics Biotech Inc, Key Employee Biographies 8

Oncolytics Biotech Inc, Major Products and Services 9

Oncolytics Biotech Inc, Number of Pipeline Products by Therapy Area 10

Oncolytics Biotech Inc, Number of Pipeline Products by Development Stage 11

Oncolytics Biotech Inc, History 12

Oncolytics Biotech Inc, Subsidiaries 14

Oncolytics Biotech Inc, Key Competitors 21

Oncolytics Biotech Inc, Ratios based on current share price 22

Oncolytics Biotech Inc, Annual Ratios 23

Oncolytics Biotech Inc, Annual Ratios (Cont...1) 24

Oncolytics Biotech Inc, Interim Ratios 26

Oncolytics Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 28

Oncolytics Biotech Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 29

Oncolytics Biotech Inc, Recent Deals Summary 30

Currency Codes 41

Capital Market Ratios 41

Equity Ratios 42

Profitability Ratios 42

Cost Ratios 43

Liquidity Ratios 43

Leverage Ratios 44

Efficiency Ratios 44

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Medivation Inc Infinity Pharmaceuticals Inc Arch Biopartners Inc AngioChem Inc

Oncolytics Biotech Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license

Single User License
USD 125 INR 9065
Site License
USD 250 INR 18130
Corporate User License
USD 375 INR 27195

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com